[Experiences of the Bavarian Mammography Screening Program]

Overview

Journal Pathologe

Specialty Pathology

Date 2006 Jul 22

PMID 16858556

Authors

J Nahrig

H Hofler

S H Heywang-Kobrunner

N Prat

D Holzel

P H Wunsch

A Lebeau

Affiliations

Soon will be listed here.

Abstract

The Bavarian Mammography Screening Program started in April 2003. A detailed analysis of the consistency of diagnosis in the evaluation of vacuum-assisted stereotactic or core needle breast biopsies is presented. A total of 32 pathologists participated in a blinded evaluation of the biopsies. Each case was evaluated independently by two participating pathologists. A total of 1,357 cases were reviewed. The histopathological reports of the biopsies made by the two consulting pathologists were compared. The concordance rate of the first and second consulting pathologist was 93% for the B-classification. In general, the level of diagnostic agreement was very high for well defined, benign and malignant lesions. Some of the discrepancies resulted from the incorrect application of the B-classification. Discrepancies in the reports were also due to divergent interpretation of benign and "borderline" lesions. The protocol for the blinded evaluation of breast biopsies in two rounds assured a high level of quality. In conclusion, prerequisites for the success of a mammography screening program are interdisciplinary consensus conferences and audit rounds involving pathologists.

References

Collins L, Connolly J, Page D, Goulart R, Pisano E, Fajardo L . Diagnostic agreement in the evaluation of image-guided breast core needle biopsies: results from a randomized clinical trial. Am J Surg Pathol. 2004; 28(1):126-31. DOI: 10.1097/00000478-200401000-00015. View

Sloane J, Amendoeira I, Apostolikas N, Bellocq J, Bianchi S, Boecker W . Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology. Virchows Arch. 1999; 434(1):3-10. DOI: 10.1007/s004280050297. View

Fraser J, Raza S, Chorny K, Connolly J, Schnitt S . Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications. Am J Surg Pathol. 1998; 22(12):1521-7. DOI: 10.1097/00000478-199812000-00009. View

Willgeroth F, Baumann M, Blaser D, Crispin A, Froschauer S, de Waal J . [Bavarian mammography screening program]. Radiologe. 2005; 45(3):264-8. DOI: 10.1007/s00117-005-1182-5. View

OMalley F, Mohsin S, Badve S, Bose S, Collins L, Ennis M . Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast. Mod Pathol. 2006; 19(2):172-9. DOI: 10.1038/modpathol.3800514. View

Ellis I, Humphreys S, Michell M, Pinder S, Wells C, Zakhour H . Best Practice No 179. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment. J Clin Pathol. 2004; 57(9):897-902. PMC: 1770422. DOI: 10.1136/jcp.2003.010983. View

Verkooijen H, Peterse J, Schipper M, Buskens E, Hendriks J, Pijnappel R . Interobserver variability between general and expert pathologists during the histopathological assessment of large-core needle and open biopsies of non-palpable breast lesions. Eur J Cancer. 2003; 39(15):2187-91. DOI: 10.1016/s0959-8049(03)00540-9. View

Tavassoli F . Ductal intraepithelial neoplasia of the breast. Virchows Arch. 2001; 438(3):221-7. DOI: 10.1007/s004280100394. View

Dabbs D, Carter G, Fudge M, Peng Y, Swalsky P, Finkelstein S . Molecular alterations in columnar cell lesions of the breast. Mod Pathol. 2006; 19(3):344-9. DOI: 10.1038/modpathol.3800538. View

10.

Heywang-Kobrunner S, Schreer I, Decker T, Bocker W . Interdisciplinary consensus on the use and technique of vacuum-assisted stereotactic breast biopsy. Eur J Radiol. 2003; 47(3):232-6. DOI: 10.1016/s0720-048x(02)00196-1. View

11.

Simpson P, Gale T, Reis-Filho J, Jones C, Parry S, Sloane J . Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol. 2005; 29(6):734-46. DOI: 10.1097/01.pas.0000157295.93914.3b. View

12.

. The requirements of a specialist breast unit. Eur J Cancer. 2000; 36(18):2288-93. DOI: 10.1016/s0959-8049(00)00180-5. View

13.

Pinder S, Ellis I . The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification. Breast Cancer Res. 2003; 5(5):254-7. PMC: 314427. DOI: 10.1186/bcr623. View